ArticleInternational journal of hematology2026
Association of carotid intima media thickness with cardiovascular disease risk in immune thrombocytopenia.
Article in International journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeImmune thrombocytopenia (ITP) is an autoimmune disorder characterized by reduced platelet count, associated with both an increased bleeding tendency and a paradoxically elevated risk of thrombotic events. Recent evidence suggests paradoxical thrombotic risk in ITP, raising concerns about cardiovascular disease (CVD). We evaluated the role of carotid intima-media thickness (CIMT) as a marker to predict cardiovascular risk in ITP.
methodsA cross-sectional study of 100 adult patients with ITP was conducted at Beni Suef University Hospital. The mean CIMT (mCIMT) was measured by carotid ultrasonography. CVD risk was assessed using the total cholesterol/high-density lipoprotein ratio (TCHOL/HDL). Statistical analysis included logistic regression, propensity score matching, and partial least squares regression.
resultsEighteen percent of patients were classified as having high risk CVD. The median mCIMT was 0.575 mm overall, but significantly higher in high-risk patients (0.72 vs. 0.55 mm). mCIMT > 0.575 mm was independently associated with nearly 11-fold higher odds of increased CVD risk per the TCHOL/HDL ratio. Platelet count, platelet distribution width, and treatment line were not associated with CVD risk.
conclusionCarotid intima-media thickening is significantly associated with CVD risk in ITP and may serve as a non-invasive surrogate marker for early detection of atherosclerotic burden.
Indexed as
Identifiers
42720892What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.